Portfolio company
CellCo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
CellCo develops artificial intelligence and molecular simulation platforms to design programmable biomolecular systems and medicines for the pharmaceutical and biotechnology industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CellType
This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
CellRep
CellRep develops an artificial intelligence platform discovering small molecules that rejuvenate immune cells for developers of cell therapies and regenerative medicine.
Cellular Intelligence
This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.
ZipBio
The company develops artificial intelligence to design gene therapies for pharmaceutical firms and biotechnology researchers.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
